Literature DB >> 29479732

Immune activation by nucleic acids: A role in pregnancy complications.

B Konečná1, L Lauková1, B Vlková1.   

Abstract

Cell-free self-DNA or RNA may induce an immune response by activating specific sensing receptors. During pregnancy, placental nucleic acids present in the maternal circulation further activate these receptors due to the presence of unmethylated CpG islands. A higher concentration of cell-free foetal DNA is associated with pregnancy complications and a higher risk for foetal rejection. Cell-free foetal DNA originates from placental trophoblasts. It appears in different forms: free, bound to histones in nucleosomes, in neutrophil extracellular traps (NETs) and in extracellular vesicles (EVs). In several pregnancy complications, cell-free foetal DNA triggers the production of proinflammatory cytokines, and this production results in a cellular and humoral immune response. This review discusses preeclampsia, systemic lupus erythematosus, foetal growth restriction, gestational diabetes, rheumatoid arthritis and obesity in pregnancy from an immunological point of view and closely examines the different pathways that result in maternal inflammation. Understanding the role of cell-free nucleic acids, as well as the biogenesis of NETs and EVs, will help us to specify their functions or targets, which seem to be important in pregnancy complications. It is still not clear whether higher concentrations of cell-free nucleic acids in the maternal circulation are the cause or consequence of various complications. Therefore, further clinical studies and, even more importantly, animal experiments that focus on the involved immunological pathways are needed.
© 2018 The Foundation for the Scandinavian Journal of Immunology.

Entities:  

Keywords:  NETosis; exosomes; extracellular DNA; pregnancy complications

Mesh:

Substances:

Year:  2018        PMID: 29479732     DOI: 10.1111/sji.12651

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  8 in total

1.  Obstetric and neonatal complications among women with autoimmune disease.

Authors:  Andrew Williams; Katherine Grantz; Indulaxmi Seeni; Candace Robledo; Shanshan Li; Marion Ouidir; Carrie Nobles; Pauline Mendola
Journal:  J Autoimmun       Date:  2019-05-27       Impact factor: 7.094

2.  Sex Difference in Plasma Deoxyribonuclease Activity in Rats.

Authors:  Ľ Janovičová; B Gromová; D Drobná; B Konečná; E Renczés; V Borbélyová; J Hodosy; P Celec
Journal:  Physiol Res       Date:  2021-10-30       Impact factor: 1.881

Review 3.  Role of the NLRP3 Inflammasome in Preeclampsia.

Authors:  Koumei Shirasuna; Tadayoshi Karasawa; Masafumi Takahashi
Journal:  Front Endocrinol (Lausanne)       Date:  2020-02-25       Impact factor: 5.555

4.  Circulating Total Cell-Free DNA Levels Are Increased in Hypertensive Disorders of Pregnancy and Associated with Prohypertensive Factors and Adverse Clinical Outcomes.

Authors:  Lorena M Amaral; Valeria C Sandrim; Matthew E Kutcher; Frank T Spradley; Ricardo C Cavalli; Jose E Tanus-Santos; Ana C Palei
Journal:  Int J Mol Sci       Date:  2021-01-08       Impact factor: 6.208

5.  G-Protein Coupled Receptor Dysregulation May Play Roles in Severe Preeclampsia-A Weighted Gene Correlation Network Analysis of Placental Gene Expression Profile.

Authors:  Manuel S Vidal; Christian Deo T Deguit; Gracia Fe B Yu; Melissa D Amosco
Journal:  Cells       Date:  2022-02-22       Impact factor: 6.600

Review 6.  Small Non-Coding RNAs in the Human Placenta: Regulatory Roles and Clinical Utility.

Authors:  Nikita Telkar; Greg L Stewart; Michelle E Pewarchuk; David E Cohn; Wendy P Robinson; Wan L Lam
Journal:  Front Genet       Date:  2022-03-30       Impact factor: 4.599

Review 7.  Mechanisms of Key Innate Immune Cells in Early- and Late-Onset Preeclampsia.

Authors:  Ingrid Aneman; Dillan Pienaar; Sonja Suvakov; Tatjana P Simic; Vesna D Garovic; Lana McClements
Journal:  Front Immunol       Date:  2020-08-18       Impact factor: 7.561

Review 8.  DNA in extracellular vesicles: biological and clinical aspects.

Authors:  Julia Elzanowska; Christine Semira; Bruno Costa-Silva
Journal:  Mol Oncol       Date:  2020-08-19       Impact factor: 6.603

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.